REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/11/2026
Back to search
Official data from USPTO
HEMO+
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079286967Class
5, 6, 9, 10, 11, 37, 41, 42
Filing
79286967
Registration
6344136
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/12/2026
Trademark type
Combined
Nice classes
5, 6, 9, 10, 11, 37, 41, 42
Filing date
12/20/2019
Registration date
05/11/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/11/2021
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
MALYSZEK, KIMBERLY RAY
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "HEMO" with a cross with a drop shadow to the right of the wording.
Holders and representatives
Holders
HEMO PLUS S?rl
Representatives
Duane M. Byers Nixon & Vanderhye PC
Technical classification
Nice Classes
Class 5Class 6Class 9Class 10Class 11Class 37Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Concentrated pharmaceutical products for hemodialysis treatmentpackaged in drums and containersdiluted products for hemodialysis treatment; pharmaceutical products for hemodialysis and other treatments packaged in flexible bags or glass ampoulesespecially solid solutes such as glucose for rehydration and calorie intake; glycocol as a solution for irrigation of blood; mannitol as a solution for irrigation of blood; pharmaceutical preparationglucose/NaCl mixfor rehydration; pharmaceutical preparationRinger's lactate solution for hydroelectric rebalancehypovolemiamaintaining acid-base balance; pharmaceutical preparationsodium chloride for rehydration and hydroelectric rebalancewater for injection (WFI) for injectable preparations in the nature of irrigation solution for irrigation of blood; pharmaceutical preparationgeneric medical preparationsin the nature of ciprofloxacin as an antibiotic; pharmaceutical preparationfluconazole as an antifungalketoprofen as an analgesic and anti-inflammatory; pharmaceutical preparationlevobupivacaine as an anesthetic; pharmaceutical preparationlevofloxacin as an antibiotic; pharmaceutical preparationmetronidazole as an antibiotic and antiparasitic; pharmaceutical preparationmorphine hydrochloride as an analgesic; pharmaceutical preparationmoxifloxacin as an antibiotic; pharmaceutical preparationofloxacin as an antibiotic; pharmaceutical preparationparacetamol as an analgesic and antipyreticropivacaine Hcl as an anaesthetic; pharmaceutical preparationtirofiban as an anticoagulant; pharmaceutical preparationzoledronic acid for patients suffering from osteoporosis; pharmaceutical preparationinjectable ampoules containing medicated preparationsquinine as an antimalarialpotassium chloride for hypokalemiahydroelectric rebalancing; pharmaceutical preparationsodium chloride for hydroelectric rebalancing; pharmaceutical preparationwater for injection (WFI) as a vehicle for parenteral administration; pharmaceutical preparationmagnesium sulfate for hypokalemiaeclampsiatorsade de pointehypocalcemia; pharmaceutical preparationsodium bicarbonate for metabolic acidosiscardiovascular arrest; pharmaceutical preparationglucose for carbohydrate calorie intake
Class 6
Prefabricated buildings of metal and prefabricated modular metal structures for creating premises for installation of manufacturing units for drugsconcentrated products for hemodialysis treatment and care premises for hemodialysis treatment provided to patients suffering from kidney disorders
Class 9
Data processing equipment and computers for use in the medical field; data processing equipment and data processing machines for use in the medical field
Class 10
Hemodialysis machines; control instruments and apparatus in the medical fieldcontrollers for medical fluid injectorscomputer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus; measuring or testing instruments and machines in the medical fieldwearable monitors used to measure biometric data for medical useblood testing apparatus
Class 11
Waste disposal incinerators; clean rooms; clean-room installations; apparatus and machines for purifying air and water in the medical field; devices for cooling air and water in the medical fieldwater coolersevaporative air coolersair conditioning apparatus
Class 37
Installationmaintenance and repair of installationsequipment and apparatus in the medical fieldHemodialysis machinescontrol instruments and apparatus in the medical fieldcontrollers for medical fluid injectorscomputer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatusmeasuring or testing instruments and machines in the medical fieldwearable monitors used to measure biometric data for medical useblood testing apparatus; installation of clean room systems
Class 41
Educational and training servicesnamely providing classesseminarsworkshopsteachingdistance learning in the medical fieldsnamely in the field of hemodialysis; vocational retraining in the medical field; personalized coaching as a training service and as an educational service in the medical field; information relating to education; training for staff developmentteam building and organizational development in the medical field
Class 42
Technical scientific research and manufacturing project studies in the medical field; technical scientific research and manufacturing project studies and scientific research projects in the medical field; technical scientific research and manufacturing project planning; quality control of products and services in the medical field
Publications
History of USPTO decisions and trademark events.
32 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/13/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/17/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/28/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
08/27/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/23/2021
PUBO
PUBLISHED FOR OPPOSITION
02/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/03/2021
ALIE
ASSIGNED TO LIE
01/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/19/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
01/19/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/19/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
01/19/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2021
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/20/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/09/2020
RFNT
REFUSAL PROCESSED BY IB
08/01/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/15/2020
RFRR
REFUSAL PROCESSED BY MPU
07/15/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/12/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/09/2020
CNRT
NON-FINAL ACTION WRITTEN
06/08/2020
DOCK
ASSIGNED TO EXAMINER
06/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/04/2020
Continuous trademark protection
Get notified about every new filing that threatens HEMO+ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.